Monograph Details

Urogenital System > Miscellaneous urogenital disorders
K-PHOS ORIGINAL
Manufacturer
Beach Pharmaceuticals
Legal Classification
Rx
Pharmacological Class
Urinary acidifier.
Generic Name
Potassium acid phosphate 500mg; equiv. to potassium 3.67mEq; scored tabs.
Also
K-PHOS M.F.
K-PHOS #2
Indications
Urinary acidification.
Children
Not recommended.
Adults
2 tabs dissolved in 6–8oz water 4 times a day with meals and at bedtime.
Contraindications
Renal or adrenal insufficiency. Severe hepatic disease. Infected phosphate stones. Hyperphosphatemia. Hyperkalemia (Original).
Precautions
Electrolyte restrictions. Cardiac disease. Hypertension. Edema. Monitor serum electrolytes and for GI obstruction. Discontinue if laxation persists after dosage reduction. Hypoparathyroidism. Osteomalacia. Pancreatitis. Dehydration. Toxemia of pregnancy. Pregnancy (Cat.C). Nursing mothers.
Interactions
Antagonized by antacids. Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride, potassium supplements. Toxicity with digitalis. Hypernatremia with methyldopa, guanethidine, other antihypertensives, corticotropins, mineralocorticoids.
Adverse Reactions
Small bowel lesions, laxation, headache, dizziness, hyperacidity, nausea, weakness, confusion, paresthesias, seizures, arrhythmias, shortness of breath, edema.
How Supplied
Tabs—100